Vanguard Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.66M | Buy |
|
|||||
|
2025
Q1 | $1.27M | Hold |
|
|||||
|
2024
Q4 | $1.82M | Hold |
|
|||||
|
2024
Q3 | $2.36M | Sell |
|
|||||
|
2024
Q2 | $2.3M | Buy |
|
|||||
|
2024
Q1 | $2.84M | Buy |
|
|||||
|
2023
Q4 | $2.42M | Buy |
|
|||||
|
2023
Q3 | $1.88M | Buy |
|
|||||
|
2023
Q2 | $2.21M | Buy |
|
|||||
|
2023
Q1 | $2.07M | Buy |
|
|||||
|
2022
Q4 | $1.82M | Buy |
|
|||||
|
2022
Q3 | $2.11M | Sell |
|
|||||
|
2022
Q2 | $924K | Sell |
|
|||||
|
2022
Q1 | $12M | Buy |
|
|||||
|
2021
Q4 | $21.6M | Buy |
|
|||||
|
2021
Q3 | $23.8M | Buy |
|
|||||
|
2021
Q2 | $17.8M | Buy |
|
|||||
|
2021
Q1 | $16.3M | Sell |
|
|||||
|
2020
Q4 | $21.9M | Buy |
|
|||||
|
2020
Q3 | $10.4M | Buy |
|
|||||
|
2020
Q2 | $9.95M | Buy |
|
|||||
|
2020
Q1 | $5.08M | Buy |
|
|||||
|
2019
Q4 | $4.77M | Sell |
|
|||||
|
2019
Q3 | $5.26M | Buy |
|
|||||
|
2019
Q2 | $5.03M | Buy |
|
|||||
|
2019
Q1 | $5.36M | Buy |
|
|||||
|
2018
Q4 | $1M | Sell |
|
|||||
|
2018
Q3 | $4.79M | Buy |
|
|||||
|
2018
Q2 | $1.83M | Buy |
|
|||||
|
2018
Q1 | $1.58M | Buy |
|
|||||
|
2017
Q4 | $534K | Buy |
|